SCHEMBL6663466

SCHEMBL6663466

COC(=O)C(Cc1cccc(Br)c1)NC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.52
HDAC6 Q9UBN7 3/20 0.52
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
TACR1 P25103 2/20 0.51
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ATM Q13315 1/20 0.49
CTSB P07858 1/20 0.48
CTSS P25774 1/20 0.48
CTSK P43235 1/20 0.48
ALDH1A1 P00352 1/20 0.48
THRB P10828 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663471 1.00 HDAC1 (0.52) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL19748691 0.89 CTSB (0.54) HDAC1HDAC6MEN1KMT2AATM
SCHEMBL32677013 0.89 CTSB (0.54) HDAC1HDAC6MEN1KMT2AATM
SCHEMBL14209576 0.88 HDAC1 (0.49) HDAC1HDAC6MEN1KMT2AATM
SCHEMBL4402346 0.86 HDAC3 (0.53) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL12813341 0.86 FPR2 (0.53) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL12813343 0.86 FPR2 (0.53) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL31753512 0.86 FPR2 (0.53) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL32677233 0.85 CTSB (0.51) HDAC1HDAC6MEN1KMT2AATM
SCHEMBL32677070 0.85 CTSB (0.51) HDAC1HDAC6MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1030854-B1 CATALYSTS FOR ASYMMETRIC SYNTHESIS CONTAINING RIGID CHIRAL LIGANDS PENN STATE RES FOUND (US) 2004-08-18 EP disclosed
US-6380416-B2 CHIRAL BIDENTATE PHOSPHINE LIGANDS WITH CYCLIC RINGS TO RESTRICT CONFORMATIONAL FLEXIBILITY OF THE LIGANDS TO ENHANCE EFFICIENCY; STEREOSELECTIVE HYDROGENATION OF KETONES TO ALCOHOLS, AND A-ACETOAMIDOCINNAMIC ACID TO ACYLAMINO ACIDS THE PENN STATE RESEARCH FOUNDATION 2002-04-30 US disclosed
US-20010047113-A1 Chiral bidentate phosphine ligands with cyclic rings to restrict conformational flexibility of the ligands to enhance efficiency; stereoselective hydrogenation of ketones to alcohols, and a-acetoamidocinnamic acid to acylamino acids THE PENN STATE RESEARCH FOUNDATION 2001-11-29 US disclosed
US-6278024-B1 AS CATALYSTS FOR ASSYMETRIC SYNTHESIS THE PENN STATE RESEARCH FOUNDATION 2001-08-21 US disclosed
US-6207868-B1 BASED ON CHIRAL BIDENTATE PHOSPHINE LIGANDS WITH CYCLIC RING STRUCTURES TO RESTRICT CONFORMATIONAL FLEXIBILITY, ASYMMETRIC SYNTHESIS OF ALCOHOLS BY ENANTIOSELECTIVE HYDROGENATION OF KETONES CATALYZED BY THE CHIRAL LIGANDS THE PENN STATE RESEARCH FOUNDATION 2001-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010047113-A1 Chiral bidentate phosphine ligands with cyclic rings to restrict conformational flexibility of the ligands to enhance efficiency; stereoselective hydrogenation of ketones to alcohols, and a-acetoamidocinnamic acid to acylamino acids ADH1A, AASDHPPT, AADAT HDAC1 578/4885HDAC6 724/4885HDAC3 1424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.